|
|
Article: Clinic Roundup.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Actelion Ltd., of South San Francisco, Calif., is recruiting for two new clinical trials in patients with pulmonary hypertension secondary to sickle cell disease. Pulmonary hypertension occurs in about 30 percent of patients with sickle cell disease. Without treatment, only about 50 percent of patients survive beyond two years from the time of diagnosis. The ASSET clinical trial program is collecting data on measures of clinical success such as pulmonary vascular resistance, exercise capacity, clinical outcomes, which include prevention of hospitalization, decreased number of sickle cell crises, death and other important clinical assessments, and safety.
o ...
Related newspaper, magazine, and journal articles:
|
|
Article: Data from Tel-Aviv University advance knowledge in ...
Heart Disease Weekly;
August 30, 2009 ;
700+ words
... ... Weizman St., IL-64239 Tel Aviv, Israel. The publisher ... Keywords: Israel, Tel Aviv, Analgesic, Anesthetic, Cardiology, Clinical Trial Research, Coronary Artery ... Technology, Thoracotomy, Tel-Aviv University. This article ...
|
|